DermTech, Inc.
Символ: DMTK
NASDAQ
0.6906
USDПазарна цена днес
-0.2116
Съотношение P/E
0.0002
Коефициент PEG
23.91M
MRK Cap
- 0.00%
Доходност на DIV
DermTech, Inc. (DMTK) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 315.04 | 55.9 | 126.2 | 225.3 | ||||||||
balance-sheet.row.short-term-investments | 149.84 | 19.1 | 48.4 | 48.4 | ||||||||
balance-sheet.row.net-receivables | 13.74 | 2.6 | 4.2 | 3.8 | ||||||||
balance-sheet.row.inventory | 5.13 | 1 | 1.8 | 0.5 | ||||||||
balance-sheet.row.other-current-assets | 5.99 | 2.3 | 3.9 | 3.2 | ||||||||
balance-sheet.row.total-current-assets | 343.81 | 61.8 | 136 | 232.8 | ||||||||
balance-sheet.row.property-plant-equipment-net | 236.14 | 56.7 | 62.4 | 12.3 | ||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 13.9 | 3.5 | 3.5 | 3 | ||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.other-non-current-assets | 0.17 | 0 | 0.2 | 0.2 | ||||||||
balance-sheet.row.total-non-current-assets | 250.21 | 60.2 | 66 | 15.5 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 594.02 | 121.9 | 202.1 | 248.3 | ||||||||
balance-sheet.row.account-payables | 7.19 | 1.5 | 2.4 | 2.9 | ||||||||
balance-sheet.row.short-term-debt | 10.23 | 3.1 | 1.8 | 1.6 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 210.21 | 51.3 | 54.1 | 6.3 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 39.84 | 8.7 | 11.4 | 6.3 | ||||||||
balance-sheet.row.total-non-current-liabilities | 210.23 | 51.3 | 54.1 | 6.4 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 217.35 | 51.3 | 55.8 | 7.9 | ||||||||
balance-sheet.row.total-liab | 268.46 | 64.8 | 69.7 | 18.6 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 0 | ||||||||
balance-sheet.row.retained-earnings | -1568.78 | -423.9 | -323 | -206.4 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.09 | 0.2 | -0.8 | -0.1 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 1894.41 | 480.9 | 456.2 | 436.2 | ||||||||
balance-sheet.row.total-stockholders-equity | 325.56 | 57.2 | 132.4 | 229.7 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 594.02 | 121.9 | 202.1 | 248.3 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 325.56 | 57.2 | 132.4 | 229.7 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 594.02 | - | - | - | ||||||||
Total Investments | 153.31 | 22.6 | 48.4 | 48.4 | ||||||||
balance-sheet.row.total-debt | 220.44 | 54.4 | 55.8 | 7.9 | ||||||||
balance-sheet.row.net-debt | 55.24 | 17.7 | -21.9 | -169 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -100.89 | -100.9 | -116.7 | -78.3 | |||||||
cash-flows.row.depreciation-and-amortization | 5.85 | 5.8 | 4.5 | 2.3 | |||||||
cash-flows.row.deferred-income-tax | 2.55 | -29.8 | 0 | 0 | |||||||
cash-flows.row.stock-based-compensation | 18.57 | 18.6 | 18.9 | 13.3 | |||||||
cash-flows.row.change-in-working-capital | 0.01 | 0 | -2.6 | -1.2 | |||||||
cash-flows.row.account-receivables | 1.59 | 1.6 | -0.3 | -2.4 | |||||||
cash-flows.row.inventory | 0.75 | 0.8 | -1.3 | -0.4 | |||||||
cash-flows.row.account-payables | -2.53 | -1.8 | 1.9 | 4.3 | |||||||
cash-flows.row.other-working-capital | 0.2 | -0.5 | -2.8 | -2.8 | |||||||
cash-flows.row.other-non-cash-items | -3.06 | 29.3 | 0.6 | 1.9 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | -76.98 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.9 | -0.9 | -3.3 | -2.7 | |||||||
cash-flows.row.acquisitions-net | -37.72 | 1 | -0.7 | -0.1 | |||||||
cash-flows.row.purchases-of-investments | -34.39 | -34.4 | -31.5 | -48.1 | |||||||
cash-flows.row.sales-maturities-of-investments | 65.16 | 65.2 | 30.5 | 38.3 | |||||||
cash-flows.row.other-investing-activites | 37.72 | -1 | 0.7 | 0.1 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | 29.86 | 29.9 | -4.3 | -12.5 | |||||||
cash-flows.row.debt-repayment | -0.11 | -0.1 | -0.1 | -0.2 | |||||||
cash-flows.row.common-stock-issued | 5.25 | 6.2 | 0 | 158.4 | |||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | 5.41 | 0.9 | 1 | 72 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 6.08 | 6.1 | 0.9 | 230.3 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 13.2 | 0 | 0 | 0 | |||||||
cash-flows.row.net-change-in-cash | -41.04 | -41 | -98.7 | 155.7 | |||||||
cash-flows.row.cash-at-end-of-period | 175.63 | 36.7 | 81.2 | 179.9 | |||||||
cash-flows.row.cash-at-beginning-of-period | 216.67 | 77.8 | 179.9 | 24.2 | |||||||
cash-flows.row.operating-cash-flow | -76.98 | -77 | -95.3 | -62.1 | |||||||
cash-flows.row.capital-expenditure | -0.9 | -0.9 | -3.3 | -2.7 | |||||||
cash-flows.row.free-cash-flow | -77.88 | -77.9 | -98.6 | -64.8 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 15.3 | 15.3 | 14.5 | 11.8 | |||||||
income-statement-row.row.cost-of-revenue | 15.02 | 15 | 13.9 | 10.6 | |||||||
income-statement-row.row.gross-profit | 0.28 | 0.3 | 0.6 | 1.3 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 15.24 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 43.78 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 44.99 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.operating-expenses | 104.02 | 104 | 118.8 | 78.7 | |||||||
income-statement-row.row.cost-and-expenses | 119.03 | 119 | 132.7 | 89.2 | |||||||
income-statement-row.row.interest-income | 2.85 | 2.8 | 1.3 | 0.2 | |||||||
income-statement-row.row.interest-expense | 0 | 0 | 1.3 | 0 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 44.99 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 1.45 | 2.9 | 1.5 | -0.9 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.total-operating-expenses | 1.45 | 2.9 | 1.5 | -0.9 | |||||||
income-statement-row.row.interest-expense | 0 | 0 | 1.3 | 0 | |||||||
income-statement-row.row.depreciation-and-amortization | 4.18 | 5.8 | -0.1 | 1.1 | |||||||
income-statement-row.row.ebitda-caps | -99.57 | - | - | - | |||||||
income-statement-row.row.operating-income | -103.74 | -103.7 | -118.2 | -77.4 | |||||||
income-statement-row.row.income-before-tax | -100.89 | -100.9 | -116.7 | -78.3 | |||||||
income-statement-row.row.income-tax-expense | 0 | 0 | -3 | -1.4 | |||||||
income-statement-row.row.net-income | -100.11 | -100.9 | -113.7 | -77 |
Често задавани въпроси
Какво е DermTech, Inc. (DMTK) общи активи?
DermTech, Inc. (DMTK) общите активи са 121930000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 7839000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -2.269.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -2.269.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -6.545.
Какъв е общият приход на предприятието?
Общият приход е -6.782.
Каква е DermTech, Inc. (DMTK) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -100888000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 54394000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 104015000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 36741000.000.